Danaher Co. (NYSE:DHR) – Investment analysts at Piper Jaffray Companies issued their Q2 2019 earnings estimates for Danaher in a research report issued to clients and investors on Tuesday, June 11th. Piper Jaffray Companies analyst W. Quirk forecasts that the conglomerate will earn $1.18 per share for the quarter. Piper Jaffray Companies has a “Neutral” rating and a $148.00 price target on the stock. Piper Jaffray Companies also issued estimates for Danaher’s Q3 2019 earnings at $1.19 EPS, Q4 2019 earnings at $1.35 EPS, FY2019 earnings at $4.80 EPS, Q1 2020 earnings at $1.29 EPS, Q2 2020 earnings at $1.35 EPS, Q3 2020 earnings at $1.34 EPS, Q4 2020 earnings at $1.56 EPS, FY2020 earnings at $5.55 EPS and FY2021 earnings at $5.69 EPS.
Danaher (NYSE:DHR) last posted its quarterly earnings results on Thursday, April 18th. The conglomerate reported $1.07 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.01 by $0.06. The business had revenue of $4.88 billion for the quarter, compared to analyst estimates of $4.80 billion. Danaher had a net margin of 12.04% and a return on equity of 11.61%. The firm’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter last year, the business posted $0.99 EPS.
NYSE DHR opened at $138.77 on Thursday. The company has a current ratio of 2.18, a quick ratio of 1.74 and a debt-to-equity ratio of 0.32. The company has a market cap of $98.73 billion, a P/E ratio of 29.98, a PEG ratio of 2.66 and a beta of 0.95. Danaher has a 1 year low of $94.59 and a 1 year high of $139.48.
The business also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be given a $0.17 dividend. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $0.68 dividend on an annualized basis and a yield of 0.49%. Danaher’s dividend payout ratio is currently 15.04%.
In other Danaher news, SVP Angela S. Lalor sold 3,091 shares of the firm’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $132.23, for a total value of $408,722.93. Following the sale, the senior vice president now owns 38,515 shares in the company, valued at $5,092,838.45. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Alan G. Spoon sold 1,913 shares of the firm’s stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $129.52, for a total transaction of $247,771.76. Following the completion of the sale, the director now owns 86,863 shares in the company, valued at approximately $11,250,495.76. The disclosure for this sale can be found here. Insiders sold 453,448 shares of company stock worth $59,724,640 in the last 90 days. Company insiders own 11.40% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the company. Canton Hathaway LLC raised its stake in shares of Danaher by 8.7% during the first quarter. Canton Hathaway LLC now owns 12,886 shares of the conglomerate’s stock valued at $1,701,000 after acquiring an additional 1,036 shares during the last quarter. Abacus Planning Group Inc. raised its stake in Danaher by 52.3% during the fourth quarter. Abacus Planning Group Inc. now owns 9,979 shares of the conglomerate’s stock worth $225,000 after buying an additional 3,428 shares during the last quarter. Municipal Employees Retirement System of Michigan bought a new position in Danaher during the fourth quarter worth $1,705,000. IHT Wealth Management LLC raised its stake in Danaher by 5.1% during the fourth quarter. IHT Wealth Management LLC now owns 2,023 shares of the conglomerate’s stock worth $209,000 after buying an additional 98 shares during the last quarter. Finally, Mitchell Capital Management Co. raised its stake in Danaher by 20.7% during the first quarter. Mitchell Capital Management Co. now owns 12,174 shares of the conglomerate’s stock worth $1,607,000 after buying an additional 2,088 shares during the last quarter. 78.93% of the stock is owned by hedge funds and other institutional investors.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Recommended Story: Quiet Period Expirations Explained
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.